Cho-Lea Tso
Impact in
- Genetics top 2%
- Glioma Diagnosis and Treatment
- Virus-based gene therapy research
- Cancer Research top 5%
Papers in
- Oncology 14
- Cancer Immunotherapy and Biomarkers 6
- CAR-T cell therapy research 6
- Co-authors
- Arie S. Belldegrun (22 shared papers)Jean B. deKernion (14 shared papers)Linda M. Liau (9 shared papers)Timothy F. Cloughesy (8 shared papers)Robert A. Figlin (13 shared papers)Paul S. Mischel (6 shared papers)Randhir Kaboo (10 shared papers)Allan J. Pantuck (7 shared papers)
- Journals
- The Journal of Urology (7 papers)Journal of Immunotherapy (6 papers)Cancer (3 papers)Human Gene Therapy (3 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Cho-Lea Tso
33 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 90
- Genetics 350
- Cancer Research 325
- Oncology 509
- Immunology 331
- Pulmonary and Respiratory Medicine 320
Countries citing papers authored by Cho-Lea Tso
This map shows the geographic impact of Cho-Lea Tso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cho-Lea Tso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cho-Lea Tso more than expected).
Fields of papers citing papers by Cho-Lea Tso
This network shows the impact of papers produced by Cho-Lea Tso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cho-Lea Tso. The network helps show where Cho-Lea Tso may publish in the future.
Co-authors
The 25 scholars most cited alongside Cho-Lea Tso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 195 | |
| 2 | 2006 | 165 | |
| 3 | 2009 | 102 | |
| 4 | 1992 | 100 | |
| 5 | 2007 | 100 | |
| 6 | 1995 | 96 | |
| 7 | 2001 | 90 | |
| 8 | 1996 | 83 | |
| 9 | 2003 | 77 | |
| 10 | 2003 | 72 | |
| 11 | 1996 | 70 | |
| 12 | 2004 | 60 | |
| 13 | 2015 | 58 | |
| 14 | 1993 | 55 | |
| 15 | 2000 | 53 | |
| 16 | 2013 | 52 | |
| 17 | Novel kidney cancer immunotherapy based on the granulocyte-macrophage colony-stimulating factor and carbonic anhydrase IX fusion gene. | 2003 | 43 |
| 18 | 2015 | 33 | |
| 19 | 2011 | 31 | |
| 20 | 1994 | 29 |
About Cho-Lea Tso
Cho-Lea Tso is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Genetics, having authored 33 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (6 papers), Prostate Cancer Treatment and Research (6 papers), Immunotherapy and Immune Responses (6 papers), Glioma Diagnosis and Treatment (5 papers), Immune Cell Function and Interaction (4 papers), Virus-based gene therapy research (4 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Genetics (350 citations), Cancer Research (325 citations), Oncology (509 citations), Immunology (331 citations) and Pulmonary and Respiratory Medicine (320 citations). Cho-Lea Tso has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Arie S. Belldegrun, Jean B. deKernion, Linda M. Liau, Timothy F. Cloughesy, Robert A. Figlin, Paul S. Mischel, Randhir Kaboo, Allan J. Pantuck, Stanley F. Nelson and Zugen Chen. Their work appears in journals such as The Journal of Urology, Journal of Immunotherapy, Cancer, Human Gene Therapy and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.